Lumos Pharma Investor Relations Material

Lumos Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for rare diseases. The firm uses its proprietary system based on a human gene expression tool to identify novel genes associated with specific genetic diseases. The company primarily develops therapeutic options for patients with serious, rare, genetic metabolic diseases that are often limited by the efficacy, safety and cost associated with current standard of care.